| Y6M | Name: | (2R)-1,2,3,4-tetrahydroquinoline-2,7-diol | Formula: | C9 H11 N O2 | SMILES: | Oc1ccc2c(c1)NC(O)CC2 | InChi: | InChI=1S/C9H11NO2/c11-7-3-1-6-2-4-9(12)10-8(6)5-7/h1,3,5,9-12H,2,4H2 | Definition date: | 2014-03-24 | Last modified: | 2014-03-28 | Release date: | 2014-04-02 | Identifier: | (2R)-1,2,3,4-tetrahydroquinoline-2,7-diol |
|
| ZYB | Name: | 4-Fluorobenzamidoxime | Formula: | C7 H7 F N2 O | SMILES: | Fc1ccc(C(=NO)N)cc1 | InChi: | InChI=1S/C7H7FN2O/c8-6-3-1-5(2-4-6)7(9)10-11/h1-4,11H,(H2,9,10) | Definition date: | 2014-03-21 | Last modified: | 2014-03-28 | Release date: | 2014-04-02 | Identifier: | 4-fluoro-N'-hydroxybenzenecarboximidamide |
|
| YH1 | Name: | 2-amino-8-[(2-oxo-2-phenylethyl)sulfanyl]-1,9-dihydro-6H-purin-6-one | Formula: | C13 H11 N5 O2 S | SMILES: | O=C(c1ccccc1)CSc3nc2c(N=C(N)NC2=O)n3 | InChi: | InChI=1S/C13H11N5O2S/c14-12-16-10-9(11(20)18-12)15-13(17-10)21-6-8(19)7-4-2-1-3-5-7/h1-5H,6H2,(H4,14,15,16,17,18,20) | Definition date: | 2013-09-03 | Last modified: | 2014-03-28 | Release date: | 2014-04-02 | Identifier: | 2-amino-8-[(2-oxo-2-phenylethyl)sulfanyl]-1,9-dihydro-6H-purin-6-one |
|
| YH2 | Name: | 4-{[(2-amino-6-oxo-6,9-dihydro-1H-purin-8-yl)sulfanyl]methyl}benzonitrile | Formula: | C13 H10 N6 O S | SMILES: | N#Cc1ccc(cc1)CSc3nc2c(N=C(N)NC2=O)n3 | InChi: | InChI=1S/C13H10N6OS/c14-5-7-1-3-8(4-2-7)6-21-13-16-9-10(18-13)17-12(15)19-11(9)20/h1-4H,6H2,(H4,15,16,17,18,19,20) | Definition date: | 2013-09-03 | Last modified: | 2014-03-28 | Release date: | 2014-04-02 | Identifier: | 4-{[(2-amino-6-oxo-6,9-dihydro-1H-purin-8-yl)sulfanyl]methyl}benzonitrile |
|
| YH3 | Name: | 2-amino-8-{[2-(3-methylphenyl)-2-oxoethyl]sulfanyl}-1,9-dihydro-6H-purin-6-one | Formula: | C14 H13 N5 O2 S | SMILES: | O=C(c1cccc(c1)C)CSc3nc2c(N=C(N)NC2=O)n3 | InChi: | InChI=1S/C14H13N5O2S/c1-7-3-2-4-8(5-7)9(20)6-22-14-16-10-11(18-14)17-13(15)19-12(10)21/h2-5H,6H2,1H3,(H4,15,16,17,18,19,21) | Definition date: | 2013-09-04 | Last modified: | 2014-03-28 | Release date: | 2014-04-02 | Identifier: | 2-amino-8-{[2-(3-methylphenyl)-2-oxoethyl]sulfanyl}-1,9-dihydro-6H-purin-6-one |
|
| YH4 | Name: | 2-amino-8-{[2-(2-methylphenyl)-2-oxoethyl]sulfanyl}-1,7-dihydro-6H-purin-6-one | Formula: | C14 H13 N5 O2 S | SMILES: | O=C(c1ccccc1C)CSc3nc2N=C(N)NC(=O)c2n3 | InChi: | InChI=1S/C14H13N5O2S/c1-7-4-2-3-5-8(7)9(20)6-22-14-16-10-11(18-14)17-13(15)19-12(10)21/h2-5H,6H2,1H3,(H4,15,16,17,18,19,21) | Definition date: | 2013-09-04 | Last modified: | 2014-03-28 | Release date: | 2014-04-02 | Identifier: | 2-amino-8-{[2-(2-methylphenyl)-2-oxoethyl]sulfanyl}-1,7-dihydro-6H-purin-6-one |
|
| YH6 | Name: | 2-amino-8-{[2-(4-methylphenyl)-2-oxoethyl]sulfanyl}-1,7-dihydro-6H-purin-6-one | Formula: | C14 H13 N5 O2 S | SMILES: | O=C(c1ccc(cc1)C)CSc3nc2N=C(N)NC(=O)c2n3 | InChi: | InChI=1S/C14H13N5O2S/c1-7-2-4-8(5-3-7)9(20)6-22-14-16-10-11(18-14)17-13(15)19-12(10)21/h2-5H,6H2,1H3,(H4,15,16,17,18,19,21) | Definition date: | 2013-09-03 | Last modified: | 2014-03-28 | Release date: | 2014-04-02 | Identifier: | 2-amino-8-{[2-(4-methylphenyl)-2-oxoethyl]sulfanyl}-1,7-dihydro-6H-purin-6-one |
|
| LA7 | Name: | 2-(hydroxymethyl)-6-methylpyridin-3-ol | Formula: | C7 H9 N O2 | SMILES: | Oc1ccc(nc1CO)C | InChi: | InChI=1S/C7H9NO2/c1-5-2-3-7(10)6(4-9)8-5/h2-3,9-10H,4H2,1H3 | Definition date: | 2014-03-21 | Last modified: | 2014-03-28 | Release date: | 2014-04-02 | Identifier: | 2-(hydroxymethyl)-6-methylpyridin-3-ol |
|
| 2QL | Name: | (11R,12R,13R)-11,12,13,14-tetrahydronaphtho[1,2,3,4-pqr]tetraphene-11,12,13-triol | Formula: | C24 H18 O3 | SMILES: | OC6c3c(c2c1ccccc1c5c4c2c(c3)ccc4ccc5)CC(O)C6O | InChi: | InChI=1S/C24H18O3/c25-19-11-17-18(23(26)24(19)27)10-13-9-8-12-4-3-7-15-14-5-1-2-6-16(14)22(17)21(13)20(12)15/h1-10,19,23-27H,11H2/t19-,23-,24-/m1/s1 | Definition date: | 2014-01-09 | Last modified: | 2014-03-28 | Release date: | 2014-04-02 | Identifier: | (11R,12R,13R)-11,12,13,14-tetrahydronaphtho[1,2,3,4-pqr]tetraphene-11,12,13-triol |
|
| M0Y | Name: | 4-(carbamoylamino)-1-(naphthalen-1-yl)-1H-pyrazole-3-carboxamide | Formula: | C15 H13 N5 O2 | SMILES: | O=C(N)Nc1cn(nc1C(=O)N)c2cccc3c2cccc3 | InChi: | InChI=1S/C15H13N5O2/c16-14(21)13-11(18-15(17)22)8-20(19-13)12-7-3-5-9-4-1-2-6-10(9)12/h1-8H,(H2,16,21)(H3,17,18,22) | Definition date: | 2013-08-09 | Last modified: | 2014-03-28 | Release date: | 2014-04-02 | Identifier: | 4-(carbamoylamino)-1-(naphthalen-1-yl)-1H-pyrazole-3-carboxamide |
|
| M0Z | Name: | 4-(carbamoylamino)-1-(7-methoxynaphthalen-1-yl)-1H-pyrazole-3-carboxamide | Formula: | C16 H15 N5 O3 | SMILES: | O=C(N)Nc1cn(nc1C(=O)N)c2cccc3c2cc(OC)cc3 | InChi: | InChI=1S/C16H15N5O3/c1-24-10-6-5-9-3-2-4-13(11(9)7-10)21-8-12(19-16(18)23)14(20-21)15(17)22/h2-8H,1H3,(H2,17,22)(H3,18,19,23) | Definition date: | 2013-08-09 | Last modified: | 2014-03-28 | Release date: | 2014-04-02 | Identifier: | 4-(carbamoylamino)-1-(7-methoxynaphthalen-1-yl)-1H-pyrazole-3-carboxamide |
|
| 2TQ | Name: | (2S,5S)-7-oxo-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | Formula: | C7 H9 N O3 | SMILES: | O=C(O)C2N1C(=O)CC1CC2 | InChi: | InChI=1S/C7H9NO3/c9-6-3-4-1-2-5(7(10)11)8(4)6/h4-5H,1-3H2,(H,10,11)/t4-,5-/m0/s1 | Definition date: | 2014-01-30 | Last modified: | 2014-03-28 | Release date: | 2014-04-02 | Identifier: | (2S,5S)-7-oxo-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
|
| 2TZ | Name: | [(2R,5R,6R)-4-[(2S)-1-(tert-butylsulfonyl)butan-2-yl]-6-(3-chlorophenyl)-5-(4-chlorophenyl)-3-oxomorpholin-2-yl]acetic acid | Formula: | C26 H31 Cl2 N O6 S | SMILES: | Clc1cccc(c1)C3OC(C(=O)N(C3c2ccc(Cl)cc2)C(CC)CS(=O)(=O)C(C)(C)C)CC(=O)O | InChi: | InChI=1S/C26H31Cl2NO6S/c1-5-20(15-36(33,34)26(2,3)4)29-23(16-9-11-18(27)12-10-16)24(17-7-6-8-19(28)13-17)35-21(25(29)32)14-22(30)31/h6-13,20-21,23-24H,5,14-15H2,1-4H3,(H,30,31)/t20-,21+,23+,24+/m0/s1 | Definition date: | 2014-02-02 | Last modified: | 2014-03-28 | Release date: | 2014-04-02 | Identifier: | [(2R,5R,6R)-4-[(2S)-1-(tert-butylsulfonyl)butan-2-yl]-6-(3-chlorophenyl)-5-(4-chlorophenyl)-3-oxomorpholin-2-yl]acetic acid |
|
| 2U0 | Name: | (2-{[(3R,5R,6S)-1-[(1S)-2-(tert-butylsulfonyl)-1-cyclopropylethyl]-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl]methyl}-1,3-thiazol-5-yl)acetic acid | Formula: | C33 H37 Cl2 F N2 O5 S2 | SMILES: | O=S(=O)(C(C)(C)C)CC(N3C(=O)C(CC(c1cccc(Cl)c1)C3c2ccc(Cl)c(F)c2)(Cc4ncc(s4)CC(=O)O)C)C5CC5 | InChi: | InChI=1S/C33H37Cl2FN2O5S2/c1-32(2,3)45(42,43)18-27(19-8-9-19)38-30(21-10-11-25(35)26(36)13-21)24(20-6-5-7-22(34)12-20)15-33(4,31(38)41)16-28-37-17-23(44-28)14-29(39)40/h5-7,10-13,17,19,24,27,30H,8-9,14-16,18H2,1-4H3,(H,39,40)/t24-,27-,30-,33-/m1/s1 | Definition date: | 2014-02-04 | Last modified: | 2014-03-28 | Release date: | 2014-04-02 | Identifier: | (2-{[(3R,5R,6S)-1-[(1S)-2-(tert-butylsulfonyl)-1-cyclopropylethyl]-6-(4-chloro-3-fluorophenyl)-5-(3-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl]methyl}-1,3-thiazol-5-yl)acetic acid |
|
| 2U1 | Name: | 6-{[(2S,5R,6R)-4-[(1S)-2-(tert-butylsulfonyl)-1-cyclopropylethyl]-6-(3-chlorophenyl)-5-(4-chlorophenyl)-2-methyl-3-oxomorpholin-2-yl]methyl}pyridine-3-carboxylic acid | Formula: | C33 H36 Cl2 N2 O6 S | SMILES: | O=C(O)c1ccc(nc1)CC3(OC(c2cc(Cl)ccc2)C(N(C3=O)C(C4CC4)CS(=O)(=O)C(C)(C)C)c5ccc(Cl)cc5)C | InChi: | InChI=1S/C33H36Cl2N2O6S/c1-32(2,3)44(41,42)19-27(20-8-9-20)37-28(21-10-13-24(34)14-11-21)29(22-6-5-7-25(35)16-22)43-33(4,31(37)40)17-26-15-12-23(18-36-26)30(38)39/h5-7,10-16,18,20,27-29H,8-9,17,19H2,1-4H3,(H,38,39)/t27-,28-,29-,33+/m1/s1 | Definition date: | 2014-02-04 | Last modified: | 2014-03-28 | Release date: | 2014-04-02 | Identifier: | 6-{[(2S,5R,6R)-4-[(1S)-2-(tert-butylsulfonyl)-1-cyclopropylethyl]-6-(3-chlorophenyl)-5-(4-chlorophenyl)-2-methyl-3-oxomorpholin-2-yl]methyl}pyridine-3-carboxylic acid |
|
| 2U5 | Name: | 6-{[(3R,5R,6S)-1-[(1S)-2-(tert-butylsulfonyl)-1-cyclopropylethyl]-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl]methyl}pyridine-3-carboxylic acid | Formula: | C34 H38 Cl2 N2 O5 S | SMILES: | O=C(O)c1ccc(nc1)CC5(C(=O)N(C(CS(=O)(=O)C(C)(C)C)C2CC2)C(c3ccc(Cl)cc3)C(c4cccc(Cl)c4)C5)C | InChi: | InChI=1S/C34H38Cl2N2O5S/c1-33(2,3)44(42,43)20-29(21-8-9-21)38-30(22-10-13-25(35)14-11-22)28(23-6-5-7-26(36)16-23)18-34(4,32(38)41)17-27-15-12-24(19-37-27)31(39)40/h5-7,10-16,19,21,28-30H,8-9,17-18,20H2,1-4H3,(H,39,40)/t28-,29-,30-,34+/m1/s1 | Definition date: | 2014-02-05 | Last modified: | 2014-03-28 | Release date: | 2014-04-02 | Identifier: | 6-{[(3R,5R,6S)-1-[(1S)-2-(tert-butylsulfonyl)-1-cyclopropylethyl]-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-2-oxopiperidin-3-yl]methyl}pyridine-3-carboxylic acid |
|
| 2U6 | Name: | 6-{[(2R,5R,6R)-4-[(1S)-2-(tert-butylsulfonyl)-1-cyclopropylethyl]-6-(3-chlorophenyl)-5-(4-chlorophenyl)-2-methyl-3-oxomorpholin-2-yl]methyl}pyridine-3-carboxylic acid | Formula: | C33 H36 Cl2 N2 O6 S | SMILES: | O=C(O)c1ccc(nc1)CC3(OC(c2cc(Cl)ccc2)C(N(C3=O)C(C4CC4)CS(=O)(=O)C(C)(C)C)c5ccc(Cl)cc5)C | InChi: | InChI=1S/C33H36Cl2N2O6S/c1-32(2,3)44(41,42)19-27(20-8-9-20)37-28(21-10-13-24(34)14-11-21)29(22-6-5-7-25(35)16-22)43-33(4,31(37)40)17-26-15-12-23(18-36-26)30(38)39/h5-7,10-16,18,20,27-29H,8-9,17,19H2,1-4H3,(H,38,39)/t27-,28-,29-,33-/m1/s1 | Definition date: | 2014-02-05 | Last modified: | 2014-03-28 | Release date: | 2014-04-02 | Identifier: | 6-{[(2R,5R,6R)-4-[(1S)-2-(tert-butylsulfonyl)-1-cyclopropylethyl]-6-(3-chlorophenyl)-5-(4-chlorophenyl)-2-methyl-3-oxomorpholin-2-yl]methyl}pyridine-3-carboxylic acid |
|
| 2U7 | Name: | [(2S,5R,6R)-4-[(2S)-1-(tert-butylsulfonyl)butan-2-yl]-6-(3-chlorophenyl)-5-(4-chlorophenyl)-3-oxomorpholin-2-yl]acetic acid | Formula: | C26 H31 Cl2 N O6 S | SMILES: | Clc1cccc(c1)C3OC(C(=O)N(C3c2ccc(Cl)cc2)C(CC)CS(=O)(=O)C(C)(C)C)CC(=O)O | InChi: | InChI=1S/C26H31Cl2NO6S/c1-5-20(15-36(33,34)26(2,3)4)29-23(16-9-11-18(27)12-10-16)24(17-7-6-8-19(28)13-17)35-21(25(29)32)14-22(30)31/h6-13,20-21,23-24H,5,14-15H2,1-4H3,(H,30,31)/t20-,21-,23+,24+/m0/s1 | Definition date: | 2014-02-05 | Last modified: | 2014-03-28 | Release date: | 2014-04-02 | Identifier: | [(2S,5R,6R)-4-[(2S)-1-(tert-butylsulfonyl)butan-2-yl]-6-(3-chlorophenyl)-5-(4-chlorophenyl)-3-oxomorpholin-2-yl]acetic acid |
|
| 1WC | Name: | 4-(2-chlorophenyl)-5-methyl-1H-pyrazole | Formula: | C10 H9 Cl N2 | SMILES: | Clc1ccccc1c2c(nnc2)C | InChi: | InChI=1S/C10H9ClN2/c1-7-9(6-12-13-7)8-4-2-3-5-10(8)11/h2-6H,1H3,(H,12,13) | Definition date: | 2014-02-24 | Last modified: | 2014-03-28 | Release date: | 2014-04-02 | Identifier: | 4-(2-chlorophenyl)-5-methyl-1H-pyrazole |
|
| 1XG | Name: | (3R,7E,10E)-3-hydroxy-4-oxododeca-7,10-dienamide | Formula: | C12 H19 N O3 | SMILES: | O=C(CC/C=C/C/C=C/C)C(O)CC(=O)N | InChi: | InChI=1S/C12H19NO3/c1-2-3-4-5-6-7-8-10(14)11(15)9-12(13)16/h2-3,5-6,11,15H,4,7-9H2,1H3,(H2,13,16)/b3-2+,6-5+/t11-/m1/s1 | Definition date: | 2013-07-26 | Last modified: | 2014-03-28 | Release date: | 2014-04-02 | Identifier: | (3R,7E,10E)-3-hydroxy-4-oxododeca-7,10-dienamide |
|
| 1YZ | Name: | 4-(carbamoylamino)-1-(7-ethoxynaphthalen-1-yl)-1H-pyrazole-3-carboxamide | Formula: | C17 H17 N5 O3 | SMILES: | O=C(N)Nc1cn(nc1C(=O)N)c2cccc3c2cc(OCC)cc3 | InChi: | InChI=1S/C17H17N5O3/c1-2-25-11-7-6-10-4-3-5-14(12(10)8-11)22-9-13(20-17(19)24)15(21-22)16(18)23/h3-9H,2H2,1H3,(H2,18,23)(H3,19,20,24) | Definition date: | 2013-08-09 | Last modified: | 2014-03-28 | Release date: | 2014-04-02 | Identifier: | 4-(carbamoylamino)-1-(7-ethoxynaphthalen-1-yl)-1H-pyrazole-3-carboxamide |
|
| 40B | Name: | [hydroxy(1,1':3',1''-terphenyl-3-yl)methanediyl]bis(phosphonic acid) | Formula: | C19 H18 O7 P2 | SMILES: | O=P(O)(O)C(O)(c1cccc(c1)c3cccc(c2ccccc2)c3)P(=O)(O)O | InChi: | InChI=1S/C19H18O7P2/c20-19(27(21,22)23,28(24,25)26)18-11-5-10-17(13-18)16-9-4-8-15(12-16)14-6-2-1-3-7-14/h1-13,20H,(H2,21,22,23)(H2,24,25,26) | Definition date: | 2012-09-17 | Last modified: | 2014-03-28 | Release date: | 2014-04-02 | Identifier: | [hydroxy(1,1':3',1''-terphenyl-3-yl)methanediyl]bis(phosphonic acid) |
|
| NUD | Name: | 4-[(E)-(2-amino-4-hydroxy-5-methylphenyl)diazenyl]-N-(pyridin-2-yl)benzenesulfonamide | Formula: | C18 H17 N5 O3 S | SMILES: | O=S(=O)(Nc1ncccc1)c3ccc(/N=N/c2cc(c(O)cc2N)C)cc3 | InChi: | InChI=1S/C18H17N5O3S/c1-12-10-16(15(19)11-17(12)24)22-21-13-5-7-14(8-6-13)27(25,26)23-18-4-2-3-9-20-18/h2-11,24H,19H2,1H3,(H,20,23)/b22-21+ | Definition date: | 2013-12-16 | Last modified: | 2014-03-28 | Release date: | 2014-04-02 | Identifier: | 4-[(E)-(2-amino-4-hydroxy-5-methylphenyl)diazenyl]-N-(pyridin-2-yl)benzenesulfonamide |
|
| NUE | Name: | 4-[(E)-(2-amino-4-hydroxy-3,5-dimethylphenyl)diazenyl]-N-(pyridin-2-yl)benzenesulfonamide | Formula: | C19 H19 N5 O3 S | SMILES: | O=S(=O)(Nc1ncccc1)c3ccc(/N=N/c2cc(c(O)c(c2N)C)C)cc3 | InChi: | InChI=1S/C19H19N5O3S/c1-12-11-16(18(20)13(2)19(12)25)23-22-14-6-8-15(9-7-14)28(26,27)24-17-5-3-4-10-21-17/h3-11,25H,20H2,1-2H3,(H,21,24)/b23-22+ | Definition date: | 2013-12-16 | Last modified: | 2014-03-28 | Release date: | 2014-04-02 | Identifier: | 4-[(E)-(2-amino-4-hydroxy-3,5-dimethylphenyl)diazenyl]-N-(pyridin-2-yl)benzenesulfonamide |
|
| 9Z8 | Name: | 6-(2-Mercaptoacetylamino)-N-phenylhexanamide | Formula: | C14 H20 N2 O2 S | SMILES: | O=C(Nc1ccccc1)CCCCCNC(=O)CS | InChi: | InChI=1S/C14H20N2O2S/c17-13(16-12-7-3-1-4-8-12)9-5-2-6-10-15-14(18)11-19/h1,3-4,7-8,19H,2,5-6,9-11H2,(H,15,18)(H,16,17) | Definition date: | 2014-02-14 | Last modified: | 2014-03-28 | Release date: | 2014-04-02 | Identifier: | N-phenyl-6-[(sulfanylacetyl)amino]hexanamide |
|